Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 112.53%83.94M | 29.50%221.07M | 27.45%81.04M | 52.06%59.84M | 3.91%40.7M | 38.04%39.49M | 74.32%170.72M | 179.64%63.58M | -41.52%39.35M | -34.00%39.17M |
| Cost of revenue | 113.57%58.13M | 23.22%149.96M | 34.20%58.81M | 45.57%40.61M | -18.91%23.33M | 28.24%27.22M | 89.64%121.7M | 162.16%43.82M | -45.94%27.9M | -33.53%28.76M |
| Gross profit | 110.24%25.81M | 45.09%71.11M | 12.48%22.23M | 67.87%19.23M | 66.97%17.38M | 66.19%12.28M | 45.20%49.01M | 311.54%19.76M | -27.03%11.46M | -35.24%10.41M |
| Operating expense | -86.51%257K | 52.65%13.19M | 74.75%4.1M | 124.63%3.35M | 53.52%2.53M | 55.00%1.91M | 516.16%8.64M | 266.84%2.35M | 399.20%1.49M | -12.51%1.65M |
| Selling and administrative expenses | 76.66%4.04M | 52.65%13.19M | 59.18%4.37M | 90.50%3.63M | 34.91%2.91M | 24.33%2.28M | 92.99%8.64M | 243.12%2.74M | -12.85%1.91M | -21.47%2.15M |
| -General and administrative expense | 76.66%4.04M | 52.65%13.19M | 59.18%4.37M | 90.50%3.63M | 34.91%2.91M | 24.33%2.28M | 92.99%8.64M | 243.12%2.74M | -12.85%1.91M | -21.47%2.15M |
| Total other operating income | 896.83%3.78M | -32.23%1.31M | -32.33%270K | -31.73%284K | -25.99%373K | -37.66%379K | -37.34%1.93M | 177.97%399K | -84.51%416K | -41.19%504K |
| Operating profit | 146.38%25.55M | 43.47%57.92M | 4.09%18.13M | 59.39%15.89M | 69.50%14.85M | 68.43%10.37M | 24.79%40.37M | 319.46%17.42M | -38.47%9.97M | -38.26%8.76M |
| Net non-operating interest income (expenses) | 77.39%-64K | -337.97%-773.88K | 37.20%-211K | -32.47%-359K | -227.27%-360K | -180.20%-283K | -175.15%-176.7K | -210.84%-336K | -316.92%-271K | -10,900.00%-110K |
| Non-operating interest income | ---- | -31.55%439.54K | ---- | ---- | ---- | ---- | 61.02%642.09K | ---- | ---- | ---- |
| Non-operating interest expense | -77.39%64K | 48.20%1.21M | -37.20%211K | 32.47%359K | 227.27%360K | 180.20%283K | 400.40%818.79K | 251.37%336K | 316.92%271K | 10,900.00%110K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 0 | 7.01%-4.46K | 0.00%-2K | -1K | 66.67%-1K | -1K | -160.60%-4.8K | -1,350.00%-2K | 0 | -50.00%-3K |
| Special income (charges) | 0 | |||||||||
| Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non-operating income (expenses) | -32.36%869.38K | 1.29M | ||||||||
| Income before tax | 152.69%25.49M | 39.87%58.01M | 4.91%17.92M | 60.13%15.53M | 67.54%14.48M | 66.55%10.09M | 27.28%41.48M | 144.23%17.08M | -39.90%9.7M | 2,051.47%8.65M |
| Income tax | 154.65%6.18M | 42.71%14.31M | 4.71%4.38M | 55.98%3.92M | 77.29%3.58M | 85.20%2.43M | 37.79%10.02M | 345.65%4.18M | -24.78%2.51M | -38.57%2.02M |
| Net income | 152.06%19.3M | 38.97%43.71M | 4.97%13.54M | 61.58%11.61M | 64.57%10.9M | 61.39%7.66M | 24.26%31.45M | 48.32%12.9M | -43.85%7.19M | 277.44%6.62M |
| Net income continuous operations | 152.06%19.3M | 38.97%43.71M | 4.97%13.54M | 61.58%11.61M | 64.57%10.9M | 61.39%7.66M | 24.26%31.45M | 48.32%12.9M | -43.85%7.19M | 277.44%6.62M |
| Noncontrolling interests | 4.28M | 3.49M | 1.89M | 1.6M | 0 | 0 | 0 | 0 | ||
| Net income attributable to the company | 96.23%15.03M | 27.88%40.22M | -9.70%11.65M | 39.38%10.02M | 64.57%10.9M | 61.39%7.66M | 24.26%31.45M | 48.32%12.9M | -43.85%7.19M | 277.44%6.62M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 96.23%15.03M | 27.88%40.22M | -9.70%11.65M | 39.38%10.02M | 64.57%10.9M | 61.39%7.66M | 24.26%31.45M | 48.32%12.9M | -43.85%7.19M | 277.44%6.62M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 94.12%0.0066 | 28.26%0.0177 | -10.53%0.0051 | 37.50%0.0044 | 65.52%0.0048 | 61.90%0.0034 | 24.32%0.0138 | 90.00%0.0057 | -48.39%0.0032 | 261.11%0.0029 |
| Diluted earnings per share | 94.12%0.0066 | 28.26%0.0177 | -10.53%0.0051 | 37.50%0.0044 | 65.52%0.0048 | 61.90%0.0034 | 24.32%0.0138 | 90.00%0.0057 | -48.39%0.0032 | 261.11%0.0029 |
| Dividend per share | 0 | 0.00%0.01 | 0 | 0.01 | 0 | 0 | 0.00%0.01 | 0.01 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.